TRK fusions can drive development of a wide range of tumor types, including those you commonly see—and those you don’t. 1-3
TRK fusion cancer is heterogeneous, occurring across diverse tissue and cell lineages. 1-3
To date, oncogenic TRK fusions have been identified in at least 25
cancers, including 1-3
CNS=central nervous system.